This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03069/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03069/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03069/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB03069/identifier/drugbank/

Statements

Subject Item
n2:DB03069
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB03069 n9:DB03069
dcterms:title
Cytidine-5'-Diphospho-Beta-D-Xylose
adms:identifier
n8:DB03069 n10:46506620 n11:CXY n12:46936568
n5:IUPAC-Name
n6:271B4C0C-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4C12-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4C11-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4C0E-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4C0F-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4C10-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4C0A-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4C08-363D-11E5-9242-09173F13E4C5 n6:271B4C0B-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4C09-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4C18-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4C19-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4C13-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4C14-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4C16-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4C15-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4C17-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4C1E-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4C20-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4C21-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4C1D-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4C1C-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4C1F-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4C0D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4C1A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4C1B-363D-11E5-9242-09173F13E4C5